COPENHAGEN UNIVERSITY has a total of 19 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are PHARIS BIOTEC GMBH, FORHUMANTECH CO LTD and LARSEN BJARNE DUE.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | China | 3 | |
#4 | United States | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies | |
#6 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Bock Elisabeth | 12 |
#2 | Berezin Vladimir | 12 |
#3 | Christensen Jan Pravsgaard | 3 |
#4 | Elisabeth Bock | 3 |
#5 | Thomsen Allan Randrup | 3 |
#6 | Soroka Vladislav | 3 |
#7 | Holst Peter Johannes | 3 |
#8 | Vladimir Berezin | 2 |
#9 | Kiryushko Darya | 2 |
#10 | Vladi Berezin | 1 |
Publication | Filing date | Title |
---|---|---|
US2015252075A1 | Neuroplastin derived peptides | |
EP2121740A2 | Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins | |
CN101360759A | Neurotrophin-derived peptide sequences | |
BRPI0614419A2 | gdnf-derived peptides |